AtriCure, Inc. · 18 hours ago
Cardiac Ablation Specialist- Space Coast
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. They are seeking a Cardiac Ablation Specialist to support field sales in the cardiac operating room, train surgical staff, and provide guidance during live procedures.
BiotechnologyHealth CareMedicalMedical Device
Responsibilities
Supports field sales in the cardiac operating room and related departments
Training of surgical and OR staff personnel in the use of company devices using both didactic and hands-on laboratory approaches
Guidance and support for physicians during live surgical procedures, and utilization and/or operation of company technology
Team interaction, collaboration and strategy planning with sales, marketing and professional education
Conduct in person meetings with surgeons and support staff to discuss AtriCure technology, training programs, clinical trials, and more
Qualification
Required
Undergraduate degree in technical or scientific field or experience equivalence
Ability to communicate and collaborate effectively with people across all levels and franchises
Ability to travel 30-40%, dependent upon territory
Ability to pass account and hospital credentialing processes
Preferred
Experience working in an Operating Room, Electrophysiology (EP) Lab or Catheterization lab either through industry or clinical setting
Benefits
Car allowance, gas and cell phone reimbursement, expense account
Health care (medical, dental, vision, health savings accounts) and wellness programs (onsite fitness center or gym discounts)
401K retirement savings plan plus match
Volunteer Time Off (VTO): We encourage your community and philanthropic involvement
Extended Parental Leave
Discounted Employee Stock Purchase Program
Tuition Reimbursement
Medical & Dental beginning day 1 of employment
20 days of paid Parental Leave, in addition to maternity leave, for new moms and dads
Pet Insurance
Company
AtriCure, Inc.
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide.
Funding
Current Stage
Public CompanyTotal Funding
$201MKey Investors
U.S. Venture Partners
2020-05-12Post Ipo Equity· $175M
2005-08-05IPO
2002-06-10Series Unknown· $21M
Leadership Team
Recent News
Company data provided by crunchbase